Department of Dermatology, Rambam Health Care Campus, POB 9602, 31096 Haifa, Israel.
Acta Derm Venereol. 2019 Jan 1;99(1):72-77. doi: 10.2340/00015555-2930.
There is little consensus regarding mortality data in bullous pemphigoid (BP). The aim of this study was to evaluate mortality among a relatively large cohort of Israeli patients with BP and to perform a meta-analysis synthesizing existing data on 1-year mortality rates of patients with BP. This retrospective cohort study of 287 patients diagnosed with BP between 2000 and 2015 compared the mortality of patients with BP with age- and sex-matched control subjects in the general population. The results showed 1-, 5- and 10-year mortality rates of 26.9%, 56.9% and 69.5%, respectively, and a 3.4-fold higher risk of death. A systematic review and meta-analysis were then performed using a random effects model. Including the current study, 25 studies comprising 4,594 patients met the eligibility criteria. The pooled estimate of 1-year mortality rate was 23.5% (95% confidence interval 20.2-26.8; I2=81%; p < 0.001). The pooled 1-year mortality rate of European cohorts was prominently higher relative to the pooled rates of cohorts from the USA and Asia.
在大疱性类天疱疮(BP)患者的死亡率方面,目前尚未达成共识。本研究旨在评估相对较大的以色列 BP 患者队列的死亡率,并对 BP 患者 1 年死亡率的现有数据进行荟萃分析。这项回顾性队列研究纳入了 2000 年至 2015 年间确诊为 BP 的 287 名患者,将 BP 患者的死亡率与普通人群中年龄和性别匹配的对照者进行了比较。结果显示,1 年、5 年和 10 年的死亡率分别为 26.9%、56.9%和 69.5%,死亡风险增加了 3.4 倍。然后使用随机效应模型进行了系统评价和荟萃分析。纳入本研究后,共有 25 项包含 4594 名患者的研究符合入选标准。1 年死亡率的合并估计值为 23.5%(95%置信区间 20.2-26.8;I2=81%;p<0.001)。与来自美国和亚洲的队列的合并率相比,欧洲队列的 1 年死亡率明显更高。